An Open-Label Study to Investigate the Safety and Efficacy of Rotigotine Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease Phase 3B First published 17/09/2013 Last updated 16/02/2024 EU PAS number:EUPAS4714 Study Finalised